News & Media – Lee's Pharmaceutical
20 DEC 2018

Auransa Enters into Exclusive Licensing Agreement with China Oncology Focus Limited, an Affiliate of Lee’s Pharmaceutical Holdings, for Rights to AU018 in Greater China and Southeast Asia

PALO ALTO, CA, AND HONG KONG – December 19, 2018 – Auransa, Inc., an artificialintelligence (AI)-driven pharmaceutical company developing precision medicines in areas ofsignificant unmet medical need……





News & Media

News & Media

10/03/2020

HKBIO and Lee’s Pharm Mask Donation Campaign

03/03/2020

Donation of ERT-PCR Technology for New Coronavirus Detection Press...

30/10/2019

Lee’s Pharm Cardiovascular Products Meeting of the 30th GW-ICC

29/10/2019

Greater Pediatrics, Greater Kids, Greater China ——Ferplex of Lee’s...

21/10/2019

Pre-IND meeting to communicate the combination of recombinant fully...

14/10/2019

Building a Bridge; China-Italy Cooperation in Medical Education

24/09/2019

Wen Guohui, Deputy Secretary of the CPC Guangzhou Municipal Committee...

04/09/2019

Zhaoke (Guangzhou)Oncology Pharmaceutical Ltd.had a very successful...

01/09/2019

East Meets West – Lee’s Pharm 9th Perinatal Medical Forum in...

20/08/2019

INOMAX pre-NDA meeting

02/04/2019

RegeneRx and Lee’s Pharm to Accelerate RGN-259 Development in China

20/12/2018

Auransa Enters into Exclusive Licensing Agreement with China Oncology...

06/09/2018

SillaJen and Lee’s Pharmaceutical Announce First Patient Enrolled in...